Dudediligence.

AN2 Therapeutics, Inc

ANTXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$6,080,268

1 notice · 1,012,000 sh

Oct 2025 to Oct 2026

Reported ·

$398,265

22 sales · 1 buy · $11,602 bought

Oct 2025 to Sep 2026

The two figures cover different periods.

8 of 22 reported sales carry the 10b5-1 box. Together they are 0.30% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-08-17: Readnour Robin Shane, Form 1442025-11-04: Prior Stephen David, sold2025-11-04: Eizen Joshua M, sold2026-01-05: Eizen Joshua M, sold2026-01-05: Chanda Sanjay, sold2026-01-05: Prior Stephen David, sold2026-01-05: Day Lucy, sold2026-03-03: Williams Sarah Joanne, sold2026-05-29: Williams Sarah Joanne, sold2026-07-08: Eizen Joshua M, sold2026-08-17: Readnour Robin Shane, sold2026-09-01: FitzPatrick Margaret M, bought2026-09-01: Williams Sarah Joanne, sold2026-09-03: Readnour Robin Shane, sold2026-09-09: Readnour Robin Shane, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-17Readnour Robin Shane, Director$6,080,268
1,012,000 shplan 2026-04-23144 ↗
Form 4, 2026-08-19: sold 35,402 at $6.01 Form 4 ↗